|
|
DaVita Clinical Research Expands in Denver - MarketWatch (press release) |
MarketWatch (press release)
|
|
|
Vessix Vascular to Present V2 Renal Denervation System™ for Hypertension at ... - PR Newswire (press release) |
PR Newswire (press release)
13, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today that it will make its first detailed public presentation of preclinical data relating to its new V2 Renal
|
|
Lomu awaits second transplant - SkySports |
SkySports
"Unfortunately none of the treatment has worked, my kidney is exactly the same as it was when I first got sick," said the 36-year-old, who needs dialysis three times a week. "I know I was fortunate to get the first transplant but there are more
|
|
Differential vascular expression and regulation of oncofetal tenascin-C and ... - UroToday |
|
Screening and identification of a renal carcinoma specific peptide from a ... - UroToday |
UroToday
To screen and identify novel markers for renal cell carcinoma, we evaluated a peptide that had been identified by phage display technology. METHODS: A renal carcinoma cell line A498 and a normal renal cell line HK-2 were used to carry out subtractive
|
|
|
|
|
<< Start < Prev 511 512 513 514 515 516 517 518 519 520 Next > End >>
|
|
Page 511 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
